Building the Science

DCCPS uses a variety of tools and methods to facilitate expansion of a scientific area. Input from the research community and collaboration with our numerous partners, including our work with centers of excellence, NCI-designated Cancer Centers, and the NCI Cohort Consortium, are always key components of our strategy.

Strategic Methods for Building the Science

Input from the research community is of critical importance and an integral part of the division’s scientific planning efforts. Likewise, our partnerships with both government and nongovernmental agencies are essential to our strategy for building the science of cancer control.

Scaling up Areas of Research: Centers of Excellence Initiatives

Growing an area of research requires intentional, guided efforts and significant investment. Over the decades, DCCPS has used centers of excellence initiatives to develop transdisciplinary research models that can more rapidly advance the science beyond earlier paradigms. We are elevating areas of emerging cancer control research even more effectively and quickly through these centers.

Scaling up Areas of Research: Leveraging NCI-Designated Cancer Centers

DCCPS supports NCI-designated P30 Cancer Centers in developing new ways to prevent, diagnose, and treat cancer. Through several recent initiatives focused on cancer control, the cancer centers have expanded their capacity to conduct research, plan strategy, facilitate professional collaborations, and implement efforts to improve health care.

Enabling Large-Scale Data Collaborations: NCI Cohort Consortium

DCCPS drives research across the cancer control spectrum by assembling cancer epidemiology cohorts into the NCI Cohort Consortium. This extramural-intramural partnership facilitates large-scale collaborations to pool data and biospecimens necessary to conduct a wide range of prospective cancer studies.

Responding to Emergent Societal Issues: COVID Serology Research

DCCPS responds to emerging public health issues that extend beyond our key mission of reducing the burden of cancer. The COVID-19 pandemic has provided a powerful example of how the division is able to rapidly scale up research by leveraging funding opportunities, partnerships, data infrastructure and linkages, and analytical expertise.

Three green origami polyhedron paper craft.

Continue To

Strategic Methods for Building the Science